WILMINGTON – The pharmaceutical giant AstraZeneca announced Saturday that it has reached an agreement to acquire rare disease specialist Alexion Pharmaceuticals Inc. for $39 billion, the largest industry deal this […]
WILMINGTON – AstraZeneca reported Monday morning that its COVID-19 vaccine has shown an average 70% efficacy rate, with potential for up to 90%, giving further confidence to the public that […]
Last week, news began to spread that AstraZeneca, the pharmaceutical giant that has its U.S. headquarters in suburban Wilmington, was putting a large, Phase 3 clinical trial of its COVID-19 […]
WILMINGTON – Pharmaceutical giant AstraZeneca announced May 21 that it will receive upward of $1.2 billion from the federal government to advance work on its COVID-19 vaccine. The Cambridge-based company, […]
Fasenra, AstraZeneca’s add-on maintenance treatment for patients with severe asthma, has received U.S. Food and Drug Administration approval. Fasenra is approved for patients 12 and older with an eosinophilic phenotype, […]
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.